Abstract
With recent technological developments, protein biomarker discoveries directly from blood have regained interest due to elevated feasibility. Mass spectrometry (MS)-based proteomics can now characterize human plasma proteomes to a greater extent than has ever been possible before. Such deep proteome coverage comes, however, with important limitations in terms of analysis time which is a critical factor in the case of clinical studies. As a consequence, compromises still need to be made to balance the proteome coverage with realistic analysis time frame in clinical research. The analysis of a sufficient number of samples is compulsory to empower statistically robust candidate biomarker findings. We have, therefore, recently developed a scalable automated proteomic pipeline (ASAP2) to enable the proteomic analysis of large numbers of plasma and cerebrospinal fluid (CSF) samples, from dozens to a thousand of samples, with the latter number being currently processed in 15 weeks. A distinct characteristic of ASAP2 relies on the possibility to prepare samples in a highly automated way, mostly using 96-well plates. We describe herein a sample preparation procedure for human plasma that includes internal standard spiking, abundant protein removal, buffer exchange, reduction, alkylation, tryptic digestion, isobaric labeling, pooling, and sample purification. Other key elements of the pipeline (i.e., study design, sample tracking, liquid chromatography (LC) tandem MS (MS/MS), data processing, and data analysis) are also highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971–983
Polanski M, Anderson NL (2007) A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 1:1–48
Anderson NL (2010) The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 56:177–185
Hernández B, Parnell A, Pennington SR (2014) Why have so few proteomic biomarkers “survived” validation? (Sample size and independent validation considerations). Proteomics 14:1587–1592
Dayon L, Kussmann M (2013) Proteomics of human plasma: a critical comparison of analytical workflows in terms of effort, throughput and outcome. EuPA Open Proteom 1:8–16
Keshishian H, Burgess MW, Gillette MA et al (2015) Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury. Mol Cell Proteomics 14:2375–2393
Dayon L, Hainard A, Licker V et al (2008) Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal Chem 80:2921–2931
Dayon L, Sanchez JC (2012) Relative protein quantification by MS/MS using the tandem mass tag technology. In: Marcus K (ed) Quantitative methods in proteomics. Methods in molecular biology, vol 893. Humana Press, Totowa, NJ, pp 115–127
Dayon L, Núñez Galindo A, Corthésy J et al (2014) Comprehensive and scalable highly automated MS-based proteomic workflow for clinical biomarker discovery in human plasma. J Proteome Res 13:3837–3845
Cominetti O, Núñez Galindo A, Corthésy J et al (2016) Proteomic biomarker discovery in 1000 human plasma samples with mass apectrometry. J Proteome Res 15:389–399
Surinova S, Schiess R, Hüttenhain R et al (2011) On the development of plasma protein biomarkers. J Proteome Res 10:5–16
Núñez Galindo A, Kussmann M, Dayon L (2015) Proteomics of cerebrospinal fluid: throughput and robustness using a scalable automated analysis pipeline for biomarker discovery. Anal Chem 87:10755–10761
Acknowledgements
We thank Guillaume Gesquiere and Gianluca Carboni from Hamilton Robotics S.A.R.L. and Martin Jech from Thermo Scientific for their support and productive collaboration.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Dayon, L., Núñez Galindo, A., Cominetti, O., Corthésy, J., Kussmann, M. (2017). A Highly Automated Shotgun Proteomic Workflow: Clinical Scale and Robustness for Biomarker Discovery in Blood. In: Greening, D., Simpson, R. (eds) Serum/Plasma Proteomics. Methods in Molecular Biology, vol 1619. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7057-5_30
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7057-5_30
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7056-8
Online ISBN: 978-1-4939-7057-5
eBook Packages: Springer Protocols